Regular Article
Intracellular Angiotensin II Increases the Long Isoform of PDGF mRNA in Rat Hepatoma Cells

https://doi.org/10.1006/jmcc.2002.2106Get rights and content

Abstract

J. L. Cook, J. F. Giardina, Z. Zhang and R. N. Re. Intracellular Angiotensin II Increases the Long Isoform of PDGF mRNA in Rat Hepatoma Cells. Journal of Molecular and Cellular Cardiology (2002) 34, 1525–1537. Our recent published studies suggest that angiotensin II (AII), generated and retained intracellularly, enhances growth of H4-II-E-C3 rat hepatoma cells, an average of 33%. Proliferation conferred by introduction of a plasmid [ Ang(-S)Exp/pSVL ] encoding a signal sequence-depleted angiotensinogen [Ang(-S)Exp] into these cells (which we have shown possess ACE and renin mRNAs) is mediated, at least in part, by enhanced PDGF-A chain mRNA production and protein secretion. The mitogenic effect is inhibited by losartan suggesting that it involves AII interaction with an AT1-like receptor. Introduction of anti-AII antibodies into the medium of these transfected cells has no effect upon growth of the cells, suggesting that AII is retained by the cells and that intracellular AII is growth stimulatory. In the present study, we sought to further characterize the intracellular localization and mode of action of Ang(-S)Exp. Consistent with our expectations, we now show that a fusion product of Ang(-S)Exp with green fluorescent protein [Ang(-S)Exp/EGFP], generated from an expression plasmid, is abundant and primarily cytoplasmic. Wild-type angiotensinogen/EGFP, in contrast, is only detectable following a cold-block (which acts to enhance folding-kinetics and slow secretion) and is largely restricted to the secretory pathway. We further show, using semi-quantitative RT/PCR that the long isoform of PDGF mRNA is elevated in Ang(-S)Exp transfected cells and in AII-treated naive cells but not in losartan-treated Ang(-S)Exp transfected cells. We identify C-terminal amidation recognition sites within the long-form protein (that are not present in the short-form) and show that these cells possess PAM (amidating enzyme precursor) and carboxypeptidase E mRNAs (the corresponding proteins of which are sufficient for amidation). Inhibitors of amidation inhibit growth of naive and Ang(-S)Cntr/ pSVL -transfected cells (2.6-fold for phenylbutenoic acid and 3.5-fold for disulfiram treatment) but more profoundly inhibit growth of Ang(-S)Exp/pSVL -transfected cells (6.7-fold for phenylbutenoic acid and 13-fold for disulfiram). In conclusion, these data confirm that signal sequence-depleted Ang(-S)Exp is retained within cells and is largely cytoplasmic. Because C-terminal amidation is absolutely required for full biological potency of a number of peptide hormones (including oxytocin, gastrin and calcitonin), we postulate that growth effects of both intracellular AII and exogenous AII can be conferred by PDGF long-form, possibly through an amidation-dependent mechanism.

References (55)

  • LM Khachigian et al.

    Structural basis for the extracellular retention of PDGF A-chain using a synthetic peptide corresponding to exon 6

    Peptides

    (1994)
  • M Andersson et al.

    Characterization of the retention motif in the C-terminal part of the long splice form of platelet-derived growth factor A-chain

    J Biol Chem

    (1994)
  • RN Re

    The origins of intracrine hormone action

    Am J Med Sci

    (2002)
  • RN Re

    Toward a theory of intracrine hormone action

    Regulatory Peptides

    (2002)
  • JE Sealey et al.

    Specific prorenin/renin binding (ProBP). Identification and characterization of a novel membrane site

    Am J Hypertens

    (1996)
  • G Nguyen et al.

    Specific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor-1 antigen

    Kidney Int

    (1996)
  • RN Re et al.

    Specific nuclear binding of angiotensin II by rat liver and spleen nuclei

    Clin Sci

    (1981)
  • S-S Tang et al.

    Characterization of nuclear angiotensin-II-binding sites in rat liver and comparison with plasma membrane receptors

    Endocrinology

    (1992)
  • GW Booz et al.

    Angiotensin-II-binding sites on hepatocyte nuclei

    Endocrinology

    (1992)
  • AL Robertson et al.

    Angiotensin II: rapid localization in nuclei of smooth and cardiac muscle

    Science

    (1971)
  • TL Goodfriend et al.

    Clinical and conceptual uses of angiotensin receptors

  • RN Re

    Changes in nuclear initiation sites after the treatment of isolated nuclei with angiotensin II

    Clin Sci

    (1982)
  • B Erdmann et al.

    Subcellular localization of angiotensin II immunoreactivity in the rat cerebellar cortex

    Hypertension

    (1996)
  • P Eggena et al.

    Nuclear angiotensin receptors induce transcription of renin and angiotensinogen mRNA

    Hypertension

    (1993)
  • P Eggena et al.

    Hepatic angiotensin II nuclear receptors and transcription of growth-related factors

    J Hypertens

    (1996)
  • E Jimenez et al.

    Angiotensin II (AII)-binding sites in nuclei from rat liver: partial characterization of the mechanism of Ang II accumulation in nuclei

    J Endocrinol

    (1994)
  • JL Cook et al.

    In vitro evidence for an intracellular site of angiotensin action

    Circ Res

    (2001)
  • Cited by (0)

    f1

    Please address all correspondence to: Dr J. Cork, Ochsner Clinic Foundation, Division of Research, 1516 Jefferson Hwy, New Orleans, LA 70121, USA. Tel: +15048423316; Fax: +15048423381; E-mail:[email protected]

    View full text